Citadel Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.4M Sell
396,500
-493,400
-55% -$47.3M 0.01% 1720
2025
Q4
$85.5M Buy
889,900
+157,700
+22% +$15.3M 0.01% 960
2025
Q3
$69.7M Sell
732,200
-3,900
-0.5% -$359K 0.01% 1104
2025
Q2
$64.2M Sell
736,100
-834,000
-53% -$70.7M 0.01% 1045
2025
Q1
$141M Buy
1,570,100
+1,116,100
+246% +$99.9M 0.03% 509
2024
Q4
$36.3M Sell
454,000
-334,600
-42% -$29M 0.01% 1561
2024
Q3
$71M Sell
788,600
-9,900
-1% -$833K 0.01% 941
2024
Q2
$62.8M Sell
798,500
-1,469,100
-65% -$120M 0.01% 975
2024
Q1
$198M Buy
2,267,600
+1,317,300
+139% +$112M 0.04% 378
2023
Q4
$78.3M Sell
950,300
-108,500
-10% -$8.27M 0.02% 843
2023
Q3
$83M Sell
1,058,800
-97,200
-8% -$8.14M 0.02% 727
2023
Q2
$102M Sell
1,156,000
-1,059,800
-48% -$91.2M 0.02% 604
2023
Q1
$179M Buy
2,215,800
+723,100
+48% +$58.9M 0.04% 369
2022
Q4
$116M Buy
1,492,700
+428,000
+40% +$34.7M 0.03% 566
2022
Q3
$86M Buy
1,064,700
+183,600
+21% +$16.5M 0.02% 683
2022
Q2
$79.1M Sell
881,100
-20,500
-2% -$2.08M 0.02% 714
2022
Q1
$100M Sell
901,600
-411,400
-31% -$43.5M 0.02% 655
2021
Q4
$136M Buy
1,313,000
+141,700
+12% +$16.4M 0.03% 505
2021
Q3
$147M Buy
1,171,300
+553,500
+90% +$71.6M 0.03% 472
2021
Q2
$76.7M Buy
617,800
+286,000
+86% +$35.9M 0.02% 828
2021
Q1
$39.2M Sell
331,800
-262,600
-44% -$30.8M 0.01% 1256
2020
Q4
$69.6M Sell
594,400
-16,100
-3% -$1.77M 0.02% 750
2020
Q3
$63.4M Sell
610,500
-154,800
-20% -$15.5M 0.02% 705
2020
Q2
$70.2M Buy
765,300
+28,900
+4% +$2.77M 0.03% 594
2020
Q1
$66.4M Buy
736,400
+163,700
+29% +$17.4M 0.03% 516
2019
Q4
$65M Buy
572,700
+35,300
+7% +$3.87M 0.03% 625
2019
Q3
$58.4M Sell
537,400
-60,000
-10% -$6.26M 0.03% 668
2019
Q2
$58.2M Buy
597,400
+24,500
+4% +$2.24M 0.03% 651
2019
Q1
$52.2M Sell
572,900
-24,500
-4% -$2.19M 0.03% 668
2018
Q4
$54.3M Sell
597,400
-6,400
-1% -$598K 0.03% 572
2018
Q3
$59.4M Buy
603,800
+197,400
+49% +$18.3M 0.03% 660
2018
Q2
$34.8M Buy
406,400
+136,200
+50% +$11.4M 0.02% 906
2018
Q1
$21.7M Sell
270,200
-237,400
-47% -$19.6M 0.01% 1060
2017
Q4
$41M Buy
507,600
+272,000
+115% +$21.8M 0.02% 728
2017
Q3
$18.3M Sell
235,600
-42,000
-15% -$3.49M 0.01% 1126
2017
Q2
$24.6M Buy
277,600
+102,000
+58% +$8.6M 0.02% 862
2017
Q1
$14.1M Sell
175,600
-168,600
-49% -$13.2M 0.01% 1196
2016
Q4
$24.5M Sell
344,200
-81,700
-19% -$6.42M 0.02% 730
2016
Q3
$36.8M Buy
425,900
+178,300
+72% +$15.5M 0.04% 533
2016
Q2
$21.5M Buy
247,600
+29,000
+13% +$2.35M 0.02% 735
2016
Q1
$16.4M Sell
218,600
-20,700
-9% -$1.56M 0.02% 870
2015
Q4
$18.4M Sell
239,300
-72,300
-23% -$5.44M 0.02% 891
2015
Q3
$20.9M Buy
311,600
+50,300
+19% +$3.7M 0.02% 879
2015
Q2
$19.4M Buy
261,300
+85,100
+48% +$6.5M 0.02% 1028
2015
Q1
$13.7M Sell
176,200
-96,800
-35% -$7.34M 0.01% 1216
2014
Q4
$19.7M Sell
273,000
-5,100
-2% -$354K 0.02% 953
2014
Q3
$17.2M Buy
278,100
+89,800
+48% +$5.71M 0.02% 991
2014
Q2
$12M Buy
188,300
+38,400
+26% +$2.33M 0.01% 1129
2014
Q1
$9.22M Sell
149,900
-208,100
-58% -$12.1M 0.01% 1320
2013
Q4
$20.5M Buy
358,000
+111,300
+45% +$6.31M 0.03% 782
2013
Q3
$13.1M Buy
246,700
+105,900
+75% +$5.7M 0.02% 940
2013
Q2
$7.25M Buy
+140,800
New +$6.96M 0.01% 1270

Other funds holding MDT

Citadel Advisors's MDT Position: Q1 2026 in Review

Citadel Advisors reduced its Medtronic (MDT) stake by 81% in Q1 2026, selling an estimated $407M and leaving 982,741 shares worth $85.2M. The position accounts for 0.01% of the portfolio, ranked #921.

Citadel Advisors first reported a position in MDT in Q2 2013 and has held it in 52 quarters since. The position peaked at $854M in Q2 2025. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Citadel Advisors held 982,741 shares of Medtronic worth $85.2M as of Q1 2026.
  • Citadel Advisors sold 4,246,447 Medtronic shares in Q1 2026, an estimated $407M.
  • Medtronic made up 0.01% of Citadel Advisors's portfolio in Q1 2026, its #921 holding.
  • Citadel Advisors first reported a position in Medtronic in Q2 2013 and has held it in 52 quarters since.
  • Citadel Advisors's Medtronic position peaked at $854M in Q2 2025.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.